Herbalife Q1 net sales $1.3B (+1% YoY); raises full-year adjusted EBITDA guidance

the first quarter ended March 31, 2024: Highlights First Quarter 2024 • Achieved year-over-year net sales growth on both reported and constant currency basis 2 ○ Net sales of $1.3 billion, up 1.0% vs. 1Q ’23, in-line with guidance; on constant currency basis 2 up 2.4% • Net income of $24.3 million • Adjusted EBITDA 1 of $138.3 million exceeds guidance; adjusted

Proposal 1: Election of Directors. Ten board nominees for director were elected by a majority of the votes cast with respect to each nominee to serve until the 2025 annual general meeting of shareholders of the Company or until their successors are duly elected and qualified. The voting results are as follows: For Against Abstain Broker Non-votes Michael O. Johnson 66,079,357 582,448 19,226 9,921,498 Richard H. Carmona 65,747,055 915,113 18,863 9,921,498 Celine Del Genes 57,068,905 385,052 9,227,074 9,921,498 Sophie L’Hélias 66,183,554 474,934 22,543 9,921,498 Alan W. LeFevre 66,131,815 525,590 23,626 9,921,498 Michael J. Levitt 66,377,766 281,423 21,842 9,921,498 Rodica Macadrai 66,113,949 543,286 23,796 9,921,498 Juan Miguel Mendoza 66,129,687 527,738 23,606 9,921,498 Don Mulligan 56,978,797 474,785 9,227,449 9,921,498 Maria Otero 56,877,207 577,611 9,226,213 9,921,498

Proposal 4: Ratify, on an advisory basis, the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2024. The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2024 was ratified. The voting results are as follows: For Against Abstain Broker Non-votes 75,553,956 1,040,485 8,088 0

Proposal 3: Approve an amendment and restatement of the Company’s 2023 Stock Incentive Plan to increase the number of Common Shares available for issuance under such plan. The amendment and restatement of the Company’s 2023 Stock Incentive Plan to increase the number of Common Shares available for issuance under such plan was approved. The voting results are as follows: For Against Abstain Broker Non-votes 35,401,164 31,266,178 13,689 9,921,498

Proposal 2: Approve, on an advisory basis, the compensation of the Company’s named executive officers. The advisory resolution to approve the compensation of the named executive officers was approved. The voting results are as follows: For Against Abstain Broker Non-votes 55,103,969 2,345,635 9,231,427 9,921,498